ARCHIVES

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

List of core grants renewed in FY 2003, full list of center grants.

January 16, 2004

Reviewers Duck Problem Of Naming Four More Comprehensive Centers, Leave It Up To Rauscher To Pick From List Of 11

March 29, 1974

L-PAM Benefit To Post-Menopausal Patients Challenged

October 29, 1976

Centers May Become More specialized, Klausner Tells AACI

April 26, 1996

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

June 3, 2011